Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

This study has been completed.
Sponsor:
Collaborators:
McGill University Health Center
CIHR Canadian HIV Trials Network
Information provided by (Responsible Party):
Alexandra de Pokomandy, Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT00428285
First received: January 25, 2007
Last updated: July 29, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2016
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)